MIMMI, SELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.525
AS - Asia 1.062
EU - Europa 803
SA - Sud America 161
AF - Africa 13
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.571
Nazione #
US - Stati Uniti d'America 1.452
SG - Singapore 567
IT - Italia 423
CN - Cina 237
BR - Brasile 133
DE - Germania 121
IN - India 105
VN - Vietnam 70
FI - Finlandia 61
SE - Svezia 58
CA - Canada 55
GB - Regno Unito 43
FR - Francia 19
HK - Hong Kong 18
KR - Corea 14
MX - Messico 13
PL - Polonia 11
AR - Argentina 10
ES - Italia 9
ID - Indonesia 9
JP - Giappone 9
NL - Olanda 9
RO - Romania 9
CZ - Repubblica Ceca 8
ZA - Sudafrica 8
RU - Federazione Russa 7
BD - Bangladesh 6
UA - Ucraina 6
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
CL - Cile 3
CO - Colombia 3
GR - Grecia 3
MA - Marocco 3
PE - Perù 3
SA - Arabia Saudita 3
TR - Turchia 3
AT - Austria 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
JM - Giamaica 1
LK - Sri Lanka 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PW - Palau 1
PY - Paraguay 1
SR - Suriname 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.571
Città #
Dallas 324
Singapore 249
Chandler 167
Munich 92
Santa Clara 84
Catanzaro 81
Bengaluru 74
Hefei 74
Ashburn 66
Milan 66
Lawrence 60
Princeton 60
Turku 48
Beijing 41
Ottawa 31
Wilmington 30
Seattle 29
London 28
Boardman 27
Ho Chi Minh City 26
Chicago 20
Des Moines 20
Los Angeles 17
Rome 17
Hong Kong 16
Napoli 14
Brooklyn 13
Hanoi 12
Helsinki 12
São Paulo 12
Shanghai 11
Taranto 11
Augusta 9
Montreal 9
Naples 9
Redmond 9
New York 8
Olomouc 8
Redwood City 8
Foggia 7
Paris 7
Seoul 7
Guangzhou 6
Marano 6
Modena 6
Norwalk 6
Pune 6
Warsaw 6
Chennai 5
Haiphong 5
Hanover 5
Providence 5
Rio de Janeiro 5
San Francisco 5
San Jose 5
Stockholm 5
Teresina 5
The Dalles 5
Atlanta 4
Boston 4
Edmonton 4
Heidesheim 4
Johannesburg 4
Latina 4
Padova 4
Reggio Calabria 4
Shenzhen 4
Tokyo 4
Târgu Mureş 4
Washington 4
Xi'an 4
Amsterdam 3
Campinas 3
Columbus 3
Council Bluffs 3
Crosia 3
Derby 3
Dubai 3
Felgueiras 3
Ferrara 3
Florence 3
Huddinge 3
Huế 3
Lamezia Terme 3
Las Vegas 3
Mexico City 3
Mumbai 3
Redondo Beach 3
Regensburg 3
Toronto 3
Villanova d'Asti 3
Wuhan 3
Adrano 2
Auckland 2
Aversa 2
Bagnara Calabra 2
Bari 2
Bauru 2
Belgrade 2
Betim 2
Totale 2.130
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 129
A Candidate multi-targeting approach to block the CD98hc oncoprotein 93
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 92
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 88
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 79
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 77
PEPTIDI E LORO USI 74
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 74
A novel phage display based platform for exosome diversity characterization 73
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 68
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 68
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 68
Crucial role for IBtk in the survival and maintenance of mature B cells 67
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 67
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 66
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 66
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 65
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 62
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 61
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 60
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 57
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 55
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 54
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 53
Phage Display: An Overview in Context to Drug Discovery 53
Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays 53
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 52
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 51
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 51
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 51
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 50
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 50
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 49
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 47
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 47
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 47
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 47
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 47
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 46
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 46
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 45
PEPTIDE AND USES THEREO 45
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 44
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 44
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 44
Phage Display: An Overview in Context to Drug Discovery 43
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 43
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 42
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 41
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 41
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 41
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 40
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 40
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 40
Insights into Thymus Development and Viral Thymic Infections 39
Belantamab mafodotin in multiple myeloma 38
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 37
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 37
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 37
Peptide-guided targeting of GPR55 for anti-cancer therapy. 36
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 33
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 30
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 29
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 28
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 27
IN VIVO TUMOR TARGETING BY IDIOTYPE-SPECIFIC PEPTIDES 24
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 24
Isatuximab in multiple myeloma 22
Peptide-guided targeting of GPR55 for anti-cancer therapy 22
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 20
Idiotype-specific peptides as tools for the specific delivery of therapeutic compounds into tumors 20
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 20
PTPRJ negatively modulates CD98hc-CD147 complex activity in A549 lung cancer cells 19
Peptide-Guided Targeting Of Gpr55 For New Therapeutic Strategies Of Cance 17
null 10
null 6
null 2
Totale 3.673
Categoria #
all - tutte 34.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021147 0 0 0 0 5 26 16 2 33 37 18 10
2021/2022268 6 2 13 56 20 12 15 60 19 34 29 2
2022/2023559 122 26 38 23 52 37 7 53 108 38 41 14
2023/2024312 59 38 31 23 21 65 6 10 6 6 17 30
2024/20251.042 130 39 46 38 98 104 27 26 145 25 146 218
2025/20261.169 150 218 370 215 216 0 0 0 0 0 0 0
Totale 3.673